Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.92 EUR 0.69% Market Closed
Market Cap: €221.9m
Write Note Create Alert Ask AI

Atrys Health SA
Investor Relations

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

Show more
Loading
ATRY
DAX Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Santiago De Torres Sanahuja
Executive Chairman
No Bio Available
Ms. Isabel Lozano Fernandez
CEO & Executive Director
No Bio Available
Dr. Carlos Cordon-Cardo
Founder & Scientific Vice President
No Bio Available
Dr. Zvi Fuchs
Founder and Medical Vice President
No Bio Available
Mr. Jose Maria Huch Ginesta
Chief Financial Officer
No Bio Available
Luis Duran
Global Chief Technology Officer
No Bio Available
Encarna Vega
Administration Director
No Bio Available
Ms. Maria Marin
Head of Investor Relations
No Bio Available
Ms. Gabriela Camunas
General Counsel
No Bio Available
Pedro Salord
People Director
No Bio Available

Contacts

Address
MADRID
Madrid
C/ Principe de Vergara 132, 1 piso
Contacts
+34934581561
www.atryshealth.com
sparklesyt

See Also

Summary
ATRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRY stock valuation using valuation multiples.
Wall Street Estimates
ATRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.